What conditions does CellSight Technologies, Inc. run trials for?

In our tracked recruiting trials, CellSight Technologies, Inc. sponsors trials for Lung cancer, Advanced Non Small Cell Lung Cancer, HIV.

Clinical trials sponsored by CellSight Technologies, Inc.

Recruiting trials

Conditions studied

Phase 2 3

Condition	Trials
Lung cancer	2
Advanced Non Small Cell Lung Cancer	1
HIV	1
HIV Infections	1
Non-small Cell Lung Cancer	1

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
NCT06107374 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Imaging Immune Activation in HIV by PET-MR
NCT03684655 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Test-retest Evaluation of [18F]F-AraG PET
NCT06084806 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

CellSight Technologies, Inc. is the lead sponsor of 3 recruiting trials.

No. For the full record, search ClinicalTrials.gov.